Is there an association between autoimmunity and endometriosis?

Autoimmunity Reviews

Volumn 11, Issue 11, 2012, Pages 806-814

  Eisenberg, Vered H ^a   Zolti, Mati ^a   Soriano, David ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoantibodies; Autoimmunity; Endometriosis; Immunomodulation; Infertility; Pregnancy loss

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CHEMOKINE; ETANERCEPT; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PENTOXIFYLLINE; PLACEBO; PROGESTERONE; PROSTAGLANDIN; RANTES; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ALLERGY; APOPTOSIS; ARTHRITIS; ASTHMA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; ENTERITIS; FEMALE INFERTILITY; HUMAN; HUMORAL IMMUNITY; HYPOTHYROIDISM; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MEDICAL LITERATURE; MEDLINE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PERITONEUM MACROPHAGE; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; STROMA; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY; INFLAMMATION;

EID: 84865350718     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.01.005     Document Type: Review

References (137)

1. Bulun S.E. Endometriosis. N Engl J Med 2009, 360:268-279.
2. Olive D.L., Schwartz L.B. Endometriosis. N Engl J Med 1993, 328:1759.
3. Cramer D.W. Epidemiology of endometriosis. Endometriosis 1987, 5. Alan R. Liss, Inc., New York. E.A. Wilson (Ed.).
4. Strathy J.H., Molgaard C.A., Coulam C.B., Melton L.J. Endometriosis and infertility: laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril 1982, 38:667-672.
5. Mahmood T.A., Templeton A. Prevalence and genesis of endometriosis. Hum Reprod 1991, 6:544-549.
6. Sangi-Haghpeykar H., Poindexter A.N. Epidemiology of endometriosis among parous women. Obstet Gynecol 1995, 85:983-992.
7. Williams T.J., Pratt J.R. Endometriosis in 1000 consecutive celiotomies: incidence and management. Am J Obstet Gynecol 1977, 129:245-250.
8. Hasson H.M. Incidence of endometriosis in diagnostic laparoscopy. J Reprod Med 1976, 16:135-140.
9. Missmer S.A., Cramer D.W. The epidemiology of endometriosis. Obstet Gynecol Clin North Am 2003, 30:1-19.
10. Simpson J.L., Elias S., Malinak L.R., Buttram V.C. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980, 137:327-331.
11. Montgomery G.W., Nyholt D.R., Zhao Z.Z., et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008, 14:447-457.
12. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 14:422-469.
13. Halme J., Hammond M.G., Hulka J.F., Raj S.G., Talbert L.M. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984, 64:151-154.
14. Bulun S.E. Physiology and pathology of the female reproductive axis. Williams textbook of endocrinology 2011, 638-641. Elsevier, Philadelphia, PA, Chapter 17. 12 ed. S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg (Eds.).
15. Siristatidis C., Nissotakis C., Chrelias C., Iacovidou H., Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res 2006, 32(2):162-170.
16. Dmowski W.P., Steele R.N., Baker G.F. Deficient cellular immunity in endometriosis. Am J Obstet Gynecol 1981, 141:377-383.
17. Steele R.W., Dmowski W.P., Mormer D.J. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984, 6:33-36.
18. Berkkanoglu M., Arici A. Immunology and endometriosis. AJRI 2003, 50:48-59.
19. Mettler L., Volkov N.I., Kulakov V.I., Jurgenson A., Parwaresch M.R. Lymphocyte subsets in the endometrium of patients with endometriosis throughout the menstrual cycle. Am J Reprod Immunol 1996, 36:342-349.
20. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994, 62:1086-1088.
21. Kanzaki H., Wang H.S., Kariya M., Mori T. Suppression of natural killer cell activity by sera from patients with endometriosis. Am J Obstet Gynecol 1992, 167:257-261.
22. Oosterlynck D.J., Meuleman C., Waer M., Koninckx P.R., Vandeputte M. Immunosuppressive activity of peritoneal fluid in women with endometriosis. Obstet Gynecol 1993, 82:206-212.
23. Ho H.N., Wu M.Y., Yang Y.S. Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997, 38:400-412.
24. Wu M.Y., Yang J.H., Chao K.H., Hwang J.L., Yang Y.S., Ho H.N. Increase in the expression of killer cell inhibitory receptors on peritoneal natural killer cells in women with endometriosis. Fertil Steril 2000, 74:1187-1191.
25. Hsu C., Lin Y., Wang S., Huang K. Immunomodulation in women with endometriosis receiving GnRH agonists. Obstet Gynecol 1997, 89:993-998.
26. Garzetti G.G., Ciavattini A., Provinciali M., Muzzioli M., Di Stefano G., Fabris N. Natural cytotoxicity and GnRH agonist administration in advanced endometriosis: positive modulation on natural killer activity. Obstet Gynecol 1996, 88:234-240.
27. Zeller J.M., Henig I., Radwanska E., Dmowski W.P. Enhancement of human monocyte and peritoneal macrophage chemiluminescence activities in women with endometriosis. Am J Reprod Immunol Microbiol 1987, 13:78-82.
28. Halme J., Becker S., Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984, 148:85-90.
29. Halme J., Becker S., Haskill S. Altered maturation and function of peritoneal macrophages: possible role in the pathogenesis of endometriosis. Am J Obstet Gynecol 1987, 156:783-789.
30. Lebovic D.I., Mueller M.D., Taylor R.N. Immunobiology of endometriosis. Fertil Steril 2001, 75:1-10.
31. Sidell N., Han S.W., Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 2002, 955:159-173. (discussion 199-200, 396-406).
32. Nothnick W.B. Treating endometriosis as an autoimmune disease. Fertil Steril 2001, 76:223-231.
33. Viganò P., Gaffuri B., Somigliana E., Busacca M., Di Blasio A.M., Vignali M. Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998, 4:1150-1156.
34. Garcia-Velasco J.A., Arici A., Zreik T., Naftolin F., Mor G. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999, 5:642-650.
35. Selam B., Kayisli U.A., Garcia-Velasco J.A., Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod 2002, 66:1-5.
36. Lebovic D.I., Bentzien F., Chao V.A., Garett E.N., Meng Y.G., Taylor R.N. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukine-1β. Mol Hum Reprod 2000, 6:269-275.
37. Zarmakoupis P.N., Rier S.E., Maroulis G.B., Becker J.L. Inhibition of human endometrial stromal cell proliferation by interleukin 6. Hum Reprod 1995, 10:2395-2399.
38. Rier S.E., Zarmakoupis P.N., Hu X., Becker J.L. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab 1995, 80:1431-1437.
39. Schroder W., Gaetje R., Baumann R. Interleukin-6 and soluble interleukin-6 receptor in peritoneal fluid and serum of patients with endometriosis. Clin Exp Obstet Gynecol 1996, 23:10-14.
40. Arici A., Tazuke S.I., Attar E., et al. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukine-8 expression in human mesothelial cells. Mol Hum Reprod 1996, 2:40-45.
41. Gazvani M.R., Christmas S., Quenby S., et al. Peritoneal fluid concentrations of interleukine-8 in women with endometriosis: relationship to stage of disease. Hum Reprod 1998, 13:1957-1961.
42. Iwabe T., Harada T., Tsudo T., et al. Pathogenic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis. Fertil Steril 1998, 69:924-930.
43. Mazzeo D., Vigano P., Di Blasio A.M., Sinigaglia F., Vignali M., Panina-Bordignon P. Interleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: potential role in endometriosis. J Clin Endocrinol Metab 1998, 83:911-916.
44. Arici A., Oral E., Attar E., Tazuke S., Olive D.L. Monocyte chemotactic protein-1 concentration in peritoneal fluid in patients with endometriosis and its modulation in human mesothelial cells. Fertil Steril 1997, 67:1065-1072.
45. Taketani Y., Kuo T.M., Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992, 167:265-270.
46. Oosterlynck D.J., Meuleman C., Waer M., Koninckx P.R. Transforming growth factor b activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994, 83:287-292.
47. Saito T., Mizumoto H., Kuroki K., Fujii M., Moir S., Kudo R. Expression of MMP-3 and TIMP-1 in endometriosis and the influence of danazol. Acta Obstet Gynaecol Jpn 1995, 47:495-496.
48. Osteen K.G., Bruner K.L., Sharpe-Timms K.L. Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 1996, 3:247-255.
49. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F., Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997, 12:2851-2857.
50. Nisolle M., Casanas-Roux F., Anaf V., Mine J.-M., Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 1993, 59:681-684.
51. McLaren J., Prentice A., Charnock-Jones D.S., et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 1996, 98:482-489.
52. Oral E., Olive D.L., Arici A. The peritoneal environment in endometriosis. Hum Reprod Update 1997, 2:385-398.
53. Singer C.F., Marbaix E., Lemoine P., Courtoy P.J., Eeckhout Y. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 1999, 259:40-45.
54. Eisermann J., Gast M.J., Pineda J., Odem R.R., Collins J.L. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988, 50:573-579.
55. Kyama C.M., Debrock S., Mwenda J.M., D'Hooghe T.M. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003, 1:123-131.
56. Tomassetti C., Meuleman C., Pexsters A., et al. Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link?. Reprod Biomed Online 2006, 13:58-64.
57. Gleicher N., el-Roeiy A., Confino E., Friberg J. Is endometriosis an autoimmune disease?. Obstet Gynecol 1987, 70:115-122.
58. Kennedy S.H., Sargent I.L., Starkey P.M., Hicks B.R., Barlow D.H. Localization of anti-endometrial antibody binding in women with endometriosis using a double-labeling immunohistochemical method. Br J Obstet Gynaecol 1990, 97:671-674.
59. Confino E., Harlow L., Gleicher N. Peritoneal fluid and serum autoantibody levels in patients with endometriosis. Fertil Steril 1990, 53:242-245.
60. Taylor P.V., Maloney M.D., Campbell J.M., et al. Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991, 98:680-684.
61. Mathur S., Peress M.R., Williamson H.O., et al. Autoimmunity to endometrium and ovary in endometriosis. Clin Exp Immunol 1982, 50:259-266.
62. Mathur S.P. Autoimmunity in endometriosis: relevance to infertility. AJRI 2000, 44:89-95.
63. Pasoto S.G., Abrao M.S., Viana V.S., et al. Endometriosis and systemic lupus erythematosus: a comparative evaluation of clinical manifestations and serological autoimmune phenomena. Am J Reprod Immunol 2005, 53:85-93.
64. Dias J.A., de Oliveira R.M., Abrao M.S. Antinuclear antibodies and endometriosis. Int J Gynecol Obstet 2006, 93:262-263.
65. Weed J.C., Arquembourg P.C. Endometriosis. Can it produce an autoimmune response resulting in infertility?. Clin Obstet Gynecol 1980, 23:885-893.
66. Mathur S., Garza D.E., Smith L.F. Endometrial autoantigens eliciting immunoglobulin IgG, IgA, and IgM responses in endometriosis. Fertil Steril 1990, 54:56-63.
67. Badawy S.Z., Cuenca V., Stitzel A., Jacobs R.D., Tomar R.H. Autoimmune phenomena in infertile patients with endometriosis. Obstet Gynecol 1984, 63:271-275.
68. Mathur S., Chihal H.J., Homm R.J., et al. Endometrial antigens involved in autoimmunity in endometriosis. Fertil Steril 1988, 50:860-866.
69. Kennedy S.H., Starkey P.M., Sargent I.L., et al. Antiendometrial antibodies in endometriosis measured by an enzyme linked immunoabsorbent assay before and after treatment with danazol and nafarelin. Obstet Gynecol 1990, 75:914-918.
70. Wild R.A., Hirisave V., Podczaski E.S., et al. Autoantibodies associated with endometriosis: can their detection predict presence of the disease?. Obstet Gynecol 1991, 77:927-931.
71. Odukoya O.A., Wheatcroft N., Weetman A.P., et al. The prevalence of endometrial immunoglobulin G antibodies in patients with endometriosis. Hum Reprod 1995, 10:1214-1219.
72. Pillai S., Zhou G.X., Arnaud P., et al. Antibodies to endometrial transferrin and alpha 2-Heremans Schmidt (HS) glycoprotein in patients with endometriosis. Am J Reprod Immunol 1996, 35:483-494.
73. Randall G.W., Gantt P.A., Poe-Zeigler R.L., et al. Serum antiendometrial antibodies and diagnosis of endometriosis. Am J Reprod Immunol 2007, 58:374-382.
74. Mathur S.P., Holt V.L., Lee J.H., Jiang H., Rust P.F. Levels of antibodies to transferrin and a 2-HS glycoprotein in women with and without endometriosis. Am J Reprod Immunol 1998, 40:69-73.
75. Inagaki J., Sugiura-Ogasawara M., Nomizu M., et al. An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients. Hum Reprod 2003, 18:544-549.
76. Lang G.A., Yeaman G.R. Autoantibodies in endometriosis sera recognize a Thomsen-Friedenreich-like carbohydrate antigen. J Autoimmun 2001, 16:151-161.
77. Yeaman G.R., Collins J.E., Lang G.A. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 2002, 955:174-182. (discussion 199-200, 396-406).
78. Colognato H., Yurchenco P.D. Form and function: the laminin family of heterotrimers. Dev Dyn 2000, 218:213-234.
79. Inagaki J., Matsuura E., Nomizu M., et al. IgG anti-laminin-1 autoantibody and recurrent miscarriages. Am J Reprod Immunol 2001, 45:232-238.
80. Inagaki J., Kondo A., Lopez L.R., Shoenfeld Y., Matsuura E. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Ann N Y Acad Sci 2005, 1051:174-184.
81. Inagaki J., Hao L., Nakatsuka M., Yasuda T., Hiramatsu Y., Shoenfeld Y., Matsuura E. A possible mechanism of autoimmune-mediated infertility in women with endometriosis. Am J Reprod Immunol 2011, 66:90-99.
82. Lleo A., Invernizzi P., Gao B., et al. Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 2010, 9:A259-A266.
83. Barrier B.F. Immunology of endometriosis. Clin Obstet Gynecol 2010, 53:397-402.
84. Jabbour H.N., Sales K.J., Smith O.P., Battersby S., Boddy S.C. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006, 252:191-200.
85. Tamura M., Sebastian S., Gurates B., Yang S., Fang Z., Bulun S.E. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells. J Clin Endocrinol Metab 2002, 87:3504-3507.
86. Wu M.Y., Ho H.N. The role of cytokines in endometriosis. Am J Reprod Immunol 2003, 49:285-296.
87. Brenner R.M., Nayak N.R., Slayden O.D., et al. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann N Y Acad Sci 2002, 955:60-74.
88. Luk J., Seval Y., Kayisli U.A., et al. Regulation of interleukin-8 expression in human endometrial endothelial cells: a potential mechanism for the pathogenesis of endometriosis. J Clin Endocrinol Metab 2005, 90:1805-1811.
89. Ulukus M., Ulukus E.C., Tavmergen Goker E.N., et al. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril 2009, 91:687-693.
90. Ryan I.P., Tseng J.F., Schriock E.D., et al. Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril 1995, 63:929-932.
91. Bulun S.E., Cheng Y.H., Pavone M.E., Xue Q., Attar E., Trukhacheva E., et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010, 28:36-43.
92. Fazleabas A.T. Progesterone resistance in a baboon model of endometriosis. Semin Reprod Med 2010, 28:75-80.
93. Tietjen G.E., Bushnell C.D., Herial N.A., et al. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache 2007, 47:1069-1078.
94. Sinaii N., Cleary S.D., Ballweg M.L., et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002, 17:2715-2724.
95. Lamb K., Nichols T.R. Endometriosis: a comparison of associated disease histories. Am J Prev Med 1986, 2:324-329.
96. Matorras R., Ocerin I., Unamuno M., et al. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome. Lupus 2007, 16:736-740.
97. Nielsen N.M., Jorgensen K.T., Pedersen B.V., Rostgaard K., Frisch M. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011, 26:1555-1559.
98. Jess T, Frisch M, Jorgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut doi:10.1136/gutjnl-2011-301095.
99. Matarese G., De Placido G., Nikas Y., Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003, 9:223-228.
100. Sundqvist J., Falconer H., Seddighzadeh M. Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil Steril 2011, 95:437-440.
101. Witz C.A. Pathogenesis of endometriosis. Gynecol Obstet Invest 2002, 53:52-62.
102. Moen M., Bratlie A., Moen T. Distribution of HLA-antigens among patients with endometriosis. Acta Obstet Gynecol Scand Suppl 1984, 123:25-27.
103. Simpson J.L., Malinak L.R., Elias S., Carson S.A., Radvany R.A. HLA associations in endometriosis. Am J Obstet Gynecol 1984, 148:395-397.
104. Maxwell C., Kilpatrick D.C., Haining R., Smith S.K. No HLA-DR specificity is associated with endometriosis. Tissue Antigens 1989, 34:145-147.
105. Ishii K., Takakuwa K., Adach H., Higashino M., Hataya I., Tanaka K. Studies on the human leukocyte antigen class I antigens in Japanese patients with macroscopical diagnosed endometriosis. Gynecol Obstet Invest 2002, 54:150-153.
106. Ishii K., Takakuwa K., Mitsui T., Tanaka K. Studies on the human leukocyte antigen-DR in patients with endometriosis: genotyping of HLADRB1 alleles. Hum Reprod 2002, 17:560-563.
107. Ishii K., Takakuwa K., Kashima K., Tamura M., Tanaka K. Associations between patients with endometriosis and HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum Reprod 2003, 18:985-989.
108. Kitawaki J., Obayashi H., Kado N., et al. Association of HLA class I and class II alleles with susceptibility to endometriosis. Hum Immunol 2002, 11:1033-1038.
109. Wang X., Lin Q., Guo S. Study on polymorphism of human leukocyte antigen I in patients with endometriosis. Zhonghua Fu Chan Ke Za Zhi 2001, 36:150-152. (in Chinese).
110. Wang X., Liu C., Lin Q., et al. Study on polymorphism of human leukocyte antigen-DRB1 allele in patients with endometriosis. Zhonghua Fu Chan Ke Za Zhi 2002, 37:346-348. (in Chinese).
111. Zong L., He Y., Pan D. Association of human leukocyte antigen-DQA1 with endometriosis of women in southern China. Zhonghua Fu Chan Ke Za Zhi 2001, 36:405-407. (in Chinese).
112. Zong L., Pan D., Chen W., He Y., Liu Z., Lin J., Xu A. Comparative study of HLA-DQA1 and HLA-DRB1 allele in patients with endometriosis and adenomyosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002, 19:49-51. (in Chinese).
113. Whang D.H., Kim S.H., Choi Y.M., Park M.H., Noh J.H., Kim Y.B. No association between HLA-DRB1 alleles and susceptibility to advanced stage endometriosis in a Korean population. Hum Reprod 2006, 21:129-133.
114. Roszkowski P.I., Sankowska M., Jalbrzykowska A., et al. Susceptibility to ovarian endometriosis in Polish population is not associated with HLA-DRB1 alleles. Hum Reprod 2005, 20:970-973.
115. Baka S., Frangou-Plemenou M., Panagiotopoulou E., et al. The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis. Gynecol Endocrinol 2011, 27:419-424.
116. Gajbhiye R., Suryawanshi A., Khan S., Meherji P., Warty N., Raut V., Chehna N., Khole V. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online 2008, 16:817-824.
117. Inagaki J., Kondo A., Lopez L.R., Shoenfeld Y., Matsuura E. Anti-laminin-1 autoantibodies, pregnancy loss and endometriosis. Clin Dev Immunol 2004, 11:261-266.
118. Kondo A., Inagaki J., Kobayashi K., Tsukamoto H., Yamamoto D., Nakatsuka M., Suzuki N., Nomizu M., Amano S., Matsubayashi H., Yasuda T., Lopez L.R., Shoenfeld Y., Makino T., Matsuura E. Characterization of a murine anti-laminin-1 monoclonal antibody (AK8) produced by immunization with mouse-derived laminin-1. Clin Dev Immunol 2005, 12:67-73.
119. Schust D.J., Anderson D.J., Hill J.A. Progesterone-induced immunosuppression is not mediated through the progesterone receptor. Hum Reprod 1996, 5:980-985.
120. Hill J.A., Barbieri R.L., Anderson D.J. Immunosuppressive effects of danazol in vitro. Fertil Steril 1987, 48:414-418.
121. Mori H., Nakagawa M., Itoh N., Wada K., Tamaya T. Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes. Am J Reprod Immunol 1990, 24:45-50.
122. Ota H., Igarashi S., Hayakawa M., Matsui T., Tanaka H., Tanaka T. Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: a multicenter cooperative study. Fertil Steril 1996, 65:545-551.
123. Borroni R., Di Blasio A.M., Gaffuri B., et al. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate. Mol Cell Endocrinol 2000, 159:37-43.
124. Petríková J., Lazúrová I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev 2011, 10.1016/j.autrev.2011.11.010.
125. Gleicher N. Immune dysfunction-a potential target for treatment in endometriosis. Br J Obstet Gynaecol 1995, 102(suppl 12):4-7.
126. Lu D., Song H., Shi G. Anti-TNF-α treatment for pelvic pain associated with endometriosis. Cochrane database of systematic reviews 2010, Issue 3. Art. No.: CD008088. 10.1002/14651858.CD008088.pub2.
127. Balasch J., Creus M., Fabregues F., Carmona F., Martinez-Roman S., Manau D., et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod 1997, 12:2046-2050.
128. Keenan J.A., Williams-Boyce P.K., Massey P.J., Chen T.T., Caudle M.R., Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with immune modulators loxoribine and levamisole. Fertil Steril 2000, 72:135-141.
129. Ingelmo J.M., Quereda F., Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon-alpha-2b in murine model. Fertil Steril 1999, 71:907-911.
130. Somigliana E., Vigano P., Rossi G., Carinelli S., Vignali M., Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 1999, 14:2944-2950.
131. Bullimore D.W. Endometriosis is sustained by tumour necrosis factor-alpha. Med Hypotheses 2003, 60(1):84-88.
132. Nothnick W.B., Curry T.E., Vernon M.W. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol 1994, 31:151-162.
133. Lu D., Song H., Li Y., Clarke J., Shi G. Pentoxifylline versus medical therapies for subfertile women with endometriosis. Cochrane database of systematic reviews 2009, Issue 3. Art. No.: CD007677. 10.1002/14651858.CD007677.pub2.
134. Alborzi S., Ghotbi S., Parsanezhad M.E., Dehbashi S., Alborzi S., Alborzi M. Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study. J Minim Invasive Gynecol 2007, 14:54-58.
135. Creus M., Fabregues F., Carmona F., Del Pino M., Manau D., Balasch J. Combined laparoscopic surgery and pentoxifylline therapy for treatment of endometriosis-associated infertility: a preliminary trial. Hum Reprod 2008, 23:1910-1916.
136. Koninckx P.R., Craessaerts M., Timmerman D., Cornillie F., Kennedy S. Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial. Hum Reprod 2008, 23(9):2017-2023.
137. Barrier B.F., Bates G.W., Leland M.M., Leach D.A., Robinson R.D., Propst M.A. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril 2004, 81(Suppl 1):775-779.